News from NYU Langone Health
Inside NYU’s AI-powered Plan To Catch Osteoporosis With Repurposed CT Scans. (STAT)
NYU Langone Health Opens Ambulatory Center In Commack. (Newsday (NY))
(9/25) NYU Langone Health has opened the 18,000-square-foot NYU Langone Ambulatory Care Commack, offering services in family medicine, cardiology, orthopedics, plastic surgery, obstetrics and gynecology, colorectal surgery, urology, dermatology, and endocrinology, with 30 exam rooms, a procedure room, stress echocardiogram testing, and X-ray capabilities; Andrew Rubin, senior vice president for clinical affairs and ambulatory care at NYU Langone Health, said, “Our latest multispecialty practice in Commack enables patients to see multiple doctors in a single visit, with each provider connected seamlessly by our electronic health record,” marking the sixth Long Island ambulatory center opening this year, as NYU Langone Hospital—Suffolk awaits a $650 million expansion.
Also reporting is the (9/25).
Cancer Patients Are Living Longer Than Ever. Pain Drugmakers Haven’t Kept Up. (BioPharma Dive)
(9/25) In an article discussing the state of painkillers, Shengping Zou, MD, clinical associate professor, Department of Anesthesiology, Perioperative Care and Pain Medicine, and medical director at NYU Langone Health’s Center for the Study and Treatment of Pain, said, “In the last 10, 15 years, opioid pandemic issues have really scared everybody — the public, the primary care doctors, the oncologists, even the pain doctors.”
Genomic Test Predicts Metastasis Risk After Squamous Cell Carcinoma Diagnosis. (Healio)
(9/25) Two studies have demonstrated that DecisionDx-SCC, a gene expression profile test developed by Castle Biosciences, Inc., effectively predicts individual risk for metastasis following a squamous cell carcinoma diagnosis, potentially guiding adjuvant radiation therapy decisions; Désirée Ratner, MD, clinical professor, the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine, said, “What this means for patients’ care is that we can escalate or de-escalate the management of our patients depending on their risk classification.”
IBD 101: Intensive Course For GI Fellows Boosts Clinical Confidence. (GI and Hepatology News)
(9/25) Lisa B. Malter, MD, professor, Division of Gastroenterology, Department of Medicine at NYU Grossman School of Medicine, and colleagues outlined the success of the “IBD 101: Physicians and Patients Providing Pearls and Perspectives” course in Inflammatory Bowel Diseases, which has significantly increased the comfort and competence of GI fellows in managing inflammatory bowel disease, as evidenced by a 2019 pilot and subsequent surveys showing improved patient care skills; Dr. Malter said, “At this point, 1 in every 100 GI patients has IBD. It’s one of the more complex GI conditions and its incidence and prevalence are increasing globally.”
Kidney Transplant Drug Meets Phase 3 Trial Endpoint. (American Pharmaceutical Review)
ճ (9/25) Hansa Biopharma reported positive results from the US Phase 3 ConfIdeS trial of imlifidase, showing improved 12-month kidney function in highly sensitized kidney transplant patients, with Robert Montgomery, MD, DPhil, the H. Leon Pachter, MD, Professor of Surgery; chair of the Department of Surgery; and director of the NYU Langone Transplant Institute, saying, “The result from the US ConfIdeS trial are highly encouraging and demonstrate the significant potential for imlifidase to transform standard of care for highly sensitized kidney transplant patients.”
New Breast Cancer Screening Trial May Answer Key AI Question. (STAT)
(9/25)* In October, “NYU Langone Health will begin checking bone density in CT scans of people over 65 for osteoporosis, a condition that often goes undetected until someone breaks a bone,” and may “expand the work if it’s proven to help.”
AAOS Backs Biologic Implants For Rotator Cuff Repair: What To Know. (Becker's Orthopedic & Spine Review)
(9/25) The American Academy of Orthopaedic Surgeons’ updated guideline for rotator cuff repair now strongly recommends biologic implants, potentially impacting practice patterns and patient access, leading Robert J. Meislin, MD, clinical professor, Department of Orthopedic Surgery at NYU Grossman School of Medicine, to say, “For the Academy to come out and say they’re kind of giving us the green light to use it and to have their support is very exciting.”
COVID-19 Can Dull Your Sense Of Smell For Years After You Have It. (WICZ-TV Binghamton (NY))
Binghamton, NY (9/25) A study led by the National Institutes of Health’s Recover initiative and supported by the Clinical Science Core at NYU Langone Health indicates that the loss of smell due to COVID-19 may persist for years, with 80% of participants reporting changes in their smelling ability showing low scores on a scent-detection test two years post-infection; Leora Horwitz, MD, professor, Departments of Population Health, and Medicine at NYU Grossman School of Medicine, said, “Our findings confirm that those with a history of COVID-19 may be especially at risk for a weakened sense of smell, an issue that is already under-recognized among the general population.”
Also reporting is (9/25).
Leading Cancer Organizations Call For Action To Boost HPV Vaccine Coverage. (News Medical)
(9/25) NYU Langone Health’s Laura and Isaac Perlmutter Cancer Center, alongside 61 other National Cancer Institute-Designated Cancer Centers, leading national cancer health organizations, and the University of Puerto Rico Comprehensive Cancer Center, has endorsed a joint statement advocating for the HPV vaccination to prevent six types of cancer, including cervical cancer, which is almost entirely preventable through vaccination.
Jerry Shapiro, MD’s Step-By-Step Guide To Diagnosing And Managing Hair Loss. (Dermatology Times)
(9/25) At the Maui Derm NP+PA Fall Conference, Jerry Shapiro, MD, professor, the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine, delivered a comprehensive lecture on scarring alopecia, presenting a structured approach to diagnosis and management, including the use of dermoscopy and inflammation-guided treatment algorithms; he also discussed emerging therapies such as JAK inhibitors and the challenges of their accessibility, while highlighting the efficacy of platelet-rich plasma therapy and the limitations of dutasteride mesotherapy, and shared insights on female pattern hair loss treatment, emphasizing a combination of low-dose oral minoxidil and anti-androgens, as well as the importance of early diagnosis and personalized treatment regimens.
13 Orthopedic Acquisitions Happening In 2025. (Becker's Orthopedic & Spine Review)
(9/25) NYU Langone Health aԻ NYU Langone Orthopedics acquired Rothman Orthopaedics of Greater New York, as part of 13 reported acquisitions in the orthopedic space in 2025.
The Best And Worst Foods To Eat If You Have A Hernia. (Everyday Health)
(9/25) Mary Ann Hopkins, MD, professor, Division of General of Surgery, Department of Surgery at NYU Grossman School of Medicine, advises that when one has a hernia, to avoid foods that trigger digestive issues like bloating and constipation to prevent exacerbating hernia discomfort by pushing intestinal tissue further into the abdominal wall.
Possible Reasons Your Hair Is Dry, Brittle, And Falling Out. (Everyday Health)
(9/25) Mary Stevenson, MD, professor, the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine, said that chronic dry hair can lead to hair loss due to breakage, though it is possible to experience dry hair without hair loss or vice versa; she advises gentle hair care practices to prevent permanent thinning, such as using a microfiber towel to reduce friction, limiting sun exposure, and using conditioner after shampooing.
